Small Medium Large

A1CNow+®

Helps You Improve Your Patients' A1C Results

Bayer's A1CNow+® provides you with a fast and easy way of obtaining accurate A1C results in your office. This innovative technology enables you to communicate face-to-face with your patients about their diabetes control.

  • Allowing you to respond to patient data during the office visit
  • Providing your patients with immediate feedback may lower A1C by up to 1%1,2,3,4
  • Lowering A1C levels reduces risks of long term complications from diabetes5

Features

Fast
  • Provides results in just 5 minutes
  • Allows you to respond to patient data during the office visit
Easy
  • Hand-held meter allows A1C testing in every exam room
  • Test can be performed using a finger stick blood sample
  • Removes preparing and refrigerating lab samples from your office staff's workload
  • Minimizes follow-up phone calls to discuss A1C levels and possible therapeutic changes
  • No maintenance
  • CLIA waived
Accurate
  • NGSP certified (NGSP=National Glycohemoglobin Standardization Program)
  • 99% lab accuracy*

* Study results with healthcare professionals showed that the accuracy of A1CNow+ with fingerstick samples was, on average, 99%. This means that, on average, a true 7.0% A1C could read approximately 6.9%A1C. An individual A1CNow+ result may differ by as much as -1.0% A1C to +0.8% A1C from the true result. This represents the 95% confidence limits of a Bland-Altman plot.

References:

1 Miller, CD et al., Rapid A1C availability improves clinical decision-making in an urban primary care clinic. Diabetes Care 2003; 26: 1158-1163.
2 Cagliero, et al, Immediate Feedback of HbA1C Levels Improves Glycemic Control in Type 1 and Insulin-Treated Type 2 Diabetic Patients. Diabetes Care 1999, 22; 1785-1789.
3 Daniels, E. et al, Point of Care Testing to Improve Glycemic Control. Intl J or Health Care Quality Assurance 2008; 21 (3): pp. 325-335.
4 Ferenczi A et al, Effect of immediate hemoglobin A1c results on treatment decisions in office practice. J of the Am College of Endocrinology and the American Association of Clinical Endocrinologists, (2001 Mar-Apr) Volume 7, Number 2, pp. 85-8.
5 CDC's Diabetes Program-Publications & Products-National Diabetes Fact Sheet, http://www.cdc.gov/diabetes/pubs/general.htm, 9/10/2008.

Bayer, the Bayer Cross, and A1CNow+ are all registered trademarks of Bayer

print page